Introduction
============

Primary open angle glaucoma (POAG) is a progressive optic neuropathy, characterized by loss and remodeling of neural tissue, activation of glia, and altered blood flow.[@b1-opth-12-2285] Neural degeneration typically begins at the retinal ganglion cell axons, with resulting excavation of the neuroretinal rim and corresponding visual field (VF) deficits.[@b2-opth-12-2285] Traditionally, stereoscopic disc examination and VF testing have been used to detect glaucomatous disease and its progression. Stereoscopic disc examination is limited in its ability to detect subtle nerve changes,[@b3-opth-12-2285] and VF testing lacks in terms of reproducibility and patient cooperation. Thus, both are imperfect markers of glaucomatous damage.[@b4-opth-12-2285] The use of optical coherence tomography (OCT) to measure retinal nerve fiber layer (RNFL) thickness in the peripapillary region and superficial macular thickness is now widespread and has demonstrated good diagnostic utility.[@b5-opth-12-2285]--[@b11-opth-12-2285] Nonetheless, structural OCT measurements are limited in their ability to identify early disease or detect progression in late disease, have moderate correlation with VF findings,[@b12-opth-12-2285]--[@b16-opth-12-2285] and can have limited diagnostic utility in atypical optic nerves such as those in high myopes[@b17-opth-12-2285]--[@b20-opth-12-2285] or uveitis.[@b21-opth-12-2285]

While structural assessment of neural tissue loss, via OCT measures and optic nerve exam, and functional measures of glaucomatous damage, via VF testing, are currently the standard for detecting and monitoring glaucoma, several lines of evidence suggest that reduced ocular blood flow (OBF) is associated with and may even predict glaucoma.[@b22-opth-12-2285] This is consistent with the vascular pathogenic concept of glaucoma, which hypothesizes that vascular dysfunction can sometimes be a primary cause of glaucomatous nerve damage.[@b23-opth-12-2285],[@b24-opth-12-2285] While previous techniques, such as fluorescein angiography and Doppler OCT, have been able to detect overall reduced optic disc perfusion in glaucoma,[@b25-opth-12-2285]--[@b27-opth-12-2285] optical coherence tomography angiography (OCTA) provides a more precise, non-invasive means for assessing the perfused retinal microvasculature quantitatively and at specific layers of the retina.[@b28-opth-12-2285]--[@b36-opth-12-2285]

In this study, we used an optical microangiography (OMAG)-based prototype software to precisely segment the RNFL. From the generated en face images, we aimed to quantify the radial peripapillary capillaries (RPCs), which are the perfused retinal microvasculature within the RNFL,[@b37-opth-12-2285] in glaucoma and normal patients using three OCTA measures (vessel area density \[VAD\], vessel skeleton density \[VSD\], and vessel complexity index \[VCI\]),[@b38-opth-12-2285] determine its sectoral correlation with traditional structural and functional measures of glaucoma, and report the diagnostic accuracy of these OCTA measures. Characterizing the diagnostic utility of OCTA measurement of RPCs in focal peripapillary regions and comparing their correlations with traditional structural and functional measures of glaucoma may provide insight into glaucoma pathogenesis and utility of OCTA in early disease detection.

Materials and methods
=====================

Subject recruitment
-------------------

This study was performed with the participation of patients presenting to optometry and glaucoma services at the University of Southern California Roski Eye Institute. The research protocol was approved by the University of Southern California Health Sciences Campus Institutional Review Board and executed in accordance with the Declaration of Helsinki and Health Insurance Portability and Accountability Act regulations. Subjects were apprised of the nature and intent of the study, and their written informed consent was subsequently obtained.

Diagnosis of POAG was based on the assessment of a fellowship-trained glaucoma specialist, incorporating clinical exam demonstrating an optic nerve rim defect (notching or localized thinning) characteristic of glaucoma and the presence of an open angle on gonioscopy. RNFL thickness and deviation maps from OCT (Cirrus HD-OCT 5000; Carl Zeiss Meditec, Dublin, CA, USA) were retrospectively reviewed for all patients and also demonstrated focal RNFL thinning consistent with funduscopic disc findings. For perimetric glaucoma, Humphrey Swedish Interactive Threshold Algorithm 24-2 VFs had at least one of the following three: a glaucoma hemifield test outside normal limits, pattern standard deviation (PSD) outside normal limits (*P*\>0.05), or a cluster of three or more adjacent points in characteristic glaucomatous locations, all of which were reduced on the pattern deviation plot at a *P*\<5% level. POAG severity was determined based on VF testing, with "mild" POAG defined as demonstrating a global mean deviation (MD) better than −6 dB, and "moderate-severe" POAG having a global MD worse than −6 dB.[@b32-opth-12-2285],[@b39-opth-12-2285] Normal subjects in this study presented to USC clinics with non-glaucomatous optic discs, no family history of glaucoma, and intraocular pressure (IOP) ≤21 mmHg. Inclusion criteria for both glaucoma and normal groups included age ≥30 years and best corrected visual acuity of 20/40 or better. Exclusion criteria included known media opacities (significant corneal scar or cataract), macular or other retinal or optic nerve disease, history of ocular trauma or ocular surgeries other than uncomplicated cataract and glaucoma surgery, and unreliable VF tests (\>33% fixation losses, false negative, and false-positive results). OCTA images with signal strength ≥6 (out of 10) and no qualitatively observable motion, media opacity (ie, vitreous opacities), or defocus artifacts were included in the study.

All subjects underwent slit lamp biomicroscopy, IOP measurement with Goldman applanation tonometry; VF testing (Humphrey Visual Field 24-2; Zeiss); OCT imaging of RNFL thickness (Cirrus 5000 spectral-domain OCT; Zeiss); and OCT angiography imaging (Angioplex OCTA; Zeiss), obtaining 6×6 mm^2^ scans centered on the optic nerve head. The OCTA imaging system incorporated the FastTrac™ algorithm (Zeiss) to correct for motion artifact. The OCT system calculated RNFL thickness along a 3.4 mm diameter circle centered on the optic disc using the Cirrus AutoCenter™ function (Zeiss).

Clinical charts were reviewed retrospectively to obtain demographic information for both glaucomatous and normal eyes, including age, sex, IOP, central corneal thickness, glaucoma medications, blood pressure medications, history of glaucoma surgery, diabetes, hypertension, vertical cup-to-disc ratio, and average RNFL thicknesses globally and sectorally.

VF and OCTA image analysis
--------------------------

Humphrey Visual Field 24-2 global MD and PSD were recorded from the VF output. The MDs for the individual superior and inferior hemifields in each eye were calculated by obtaining weighted averages of the total deviation values in each hemifield, using weightings provided by the manufacturer and based on the instrument's normative database. This is the same procedure used for the instrument for calculation of total MD (Zeiss).

Prototype OMAG software was used to precisely segment the OCTA B-scans to create two-dimensional, 6×6 mm^2^ en face representations of the perfused RPCs of the RNFL ([Figure 1](#f1-opth-12-2285){ref-type="fig"}).[@b40-opth-12-2285] Custom quantification software with an interactive interface was used to quantify perfused retinal vascular density and morphology from three parameters for the segmented RPC en face image.[@b41-opth-12-2285] A binarized, black-and-white vessel map was extracted from the original grayscale image, using a three-way combined method consisting of a global threshold, Hessian filter, and adaptive threshold in MATLAB (R2016b, MathWorks, Inc., Natick, MA, USA). Avascular areas within the optic nerve head (ONH) were selected to serve as the threshold for background noise on an image-by-image basis to establish a baseline image-to-noise ratio. The ONH itself was then blacked out prior to quantification. Additionally, large vessels of more than 32 µm were subtracted from the blood flow en face image, allowing quantification to focus solely on the small and medium vessels. From the binarized image, a skeletonized vessel map was created by reducing the white vessel areas to a single-pixel diameter, allowing measurement of the statistical length of the moving blood column. Finally, a vessel perimeter map was created by outlining all vessels identified in the binarized image.

Each of these outputs, the binarized vessel area, skeletonized vessel length, and vessel perimeter maps were utilized in the calculation of perfusion parameters described in the following section. For all vessel parameters, quantification was limited to a circular area of radius 2.8 mm, centered in the middle of the ONH. This compensated for off-centering of the ONH and isolated the immediate peripapillary region for analysis. The area of analysis was further divided into quadrants for sectoral comparison with OCT RNFL thickness ([Figure 2](#f2-opth-12-2285){ref-type="fig"}) and hemispheres for comparison with VF data.

Using the binarized vessel map output, VAD was calculated as a unitless ratio of the total white image area (*A*~(~*~i~*~,~*~j~*~)~), representing vasculature, to the total image area (*X*~(~*~i~*~,~*~j~*~)~): $$\text{VAD} = \frac{\sum\limits_{i = 1,j = 1}^{n}A_{(i,j)}}{\sum\limits_{i = 1,j = 1}^{n}X_{(i,j)}}$$

VAD provides comprehensive information about both perfused medium vessels and capillaries in each en face OCTA image.

Using the skeletonized vessel map output, VSD was calculated as the ratio of the combined length of the one-pixel-wide vasculature (*S*~(~*~i~*~,~*~j~*~)~) to the total image area (*X*~(~*~i~*~,~*~j~*~)~, the unit of measurement being pixel/pixel[@b2-opth-12-2285]: $$\text{VSD} = \frac{\sum\limits_{i = 1,j = 1}^{n}S_{(i,j)}}{\sum\limits_{i = 1,j = 1}^{n}X_{(i,j)}}$$

Since vessel diameter was equalized in the skeletonized map, VSD emphasized perfused capillary-level vasculature and was thus a suitable marker for capillary density.

Using both the binarized vessel area map and the vessel perimeter map, the VCI was calculated by squaring the sum of the pixels on the perimeters of the vessels (*P*~(~*~i~*~,~*~j~*~)~) and dividing by 4π times the area of vasculature (*A*~(~*~i~*~,~*~j~*~)~): $$\text{VCI} = \frac{\left( {\sum\limits_{i = 1,j = 1}^{n}P_{(i,j)}} \right)^{2}}{\sum\limits_{i = 1,j = 1}^{n}A_{(i,j)}}$$

This algorithm is widely applied in the digital image processing literature[@b42-opth-12-2285] and potentially well-suited to detect tortuous, small vessels or capillary abnormalities. Theoretically, vessel tortuosity would lead to greater vessel complexity, which may have implications in the ischemic state of the retina.[@b43-opth-12-2285]

Statistical analysis
--------------------

SAS 9.4 software (SAS Institute Inc., Cary, NC, USA) and STATA 14.1 (StataCorp LP, College Station, TX, USA) were used for all data analyses. Wilcoxon rank sum tests were used to assess differences in subject-specific demographics between glaucoma and normal groups. Clustered Wilcoxon rank sum tests were performed to assess differences in eye-specific demographics between glaucoma and normal groups while controlling for inter-eye correlation, and to report differences between normal, mild POAG, and moderate-severe POAG (also controlling for inter-eye correlations). Area under receiver operating characteristic curve (AUC), controlling for age and inter-eye correlation, provided information about the diagnostic accuracy and utility of individual perfusion parameters. Intra-class correlation coefficients were calculated to test the agreement of OMAG results among three operators.

Generalized estimating equations (GEE) models were used to evaluate the strength of association between each of the perfusion parameters and RNFL thickness globally and by quadrant in POAG patients, controlling for age and inter-eye correlation. A GEE model was also used in comparing perfusion parameters with VF MD globally and across inferior and superior hemifields (inferior VF with superior perfusion, and vice versa). The beta obtained from the GEE models indicates the expected average unit increase in *y* per one unit increase in *x*.

Results
=======

Of the 123 eyes from 80 POAG patients who underwent OCTA imaging of the ONH, 38 eyes from 30 POAG patients were studied. Of 23 normal eyes from 15 control subjects imaged over the same period, 17 eyes from 12 individuals were studied. The remaining 91 eyes were excluded due to poor image quality caused by motion artifact, media opacities, poor positioning or cooperation during imaging, and/or not meeting the exclusion or inclusion criteria. Nineteen eyes had mild POAG, two of which were preperimetric, and 19 eyes had moderate-severe POAG. Of the POAG eyes, 12 had both superior and inferior VF defects, 12 had superior defects alone, 12 had inferior defects alone, and two had neither. While the average age of POAG patients was 62 years (62 for mild and 64 for moderate-severe cases) and of control subjects was 55 years, this difference was not significant (*P*=0.087). Differences in sex, hypertension, diabetes, central corneal thickness, and IOP between POAG groups and controls were also insignificant ([Table 1](#t1-opth-12-2285){ref-type="table"}). Between groups of glaucoma severity, treatment with different numbers and types of medication and with surgery did not differ significantly, with the exception of timolol treatment (*P*=0.029), with greater timolol treatment in the more severe POAG group. However, higher magnitudes of VF MD and PSD, greater cup-disc ratio, and lower RNFL thickness were associated with more advanced POAG disease severity ([Table 2](#t2-opth-12-2285){ref-type="table"}). Further, global VAD, VSD, and VCI in the RNFL microvasculature were reduced in POAG compared to normal, while controlling for inter-eye correlation. Inter-grader reliability between three users for the segmentation software was determined, with intra-class correlation coefficients of 0.922 for VAD, 0.922 for VSD, and 0.906 for VCI. Intra-grader (test--retest) reliability was also determined, with intra-class correlation coefficients of 0.999 for VAD, VSD, and VCI.

Qualitative review of RNFL microcirculation en face images showed vascular attenuation globally and focally in POAG, with larger reductions in vessel density and complexity in more severe cases ([Figures 3](#f3-opth-12-2285){ref-type="fig"} and [4](#f4-opth-12-2285){ref-type="fig"}). Quantitatively, mean global VAD was 0.371±0.024 among normal but reduced to 0.336±0.036 in mild POAG (*P*=0.010) and further reduced to 0.308±0.037 (*P*=0.035 for mild vs moderate-severe) in moderate-severe glaucoma. Similar differences were seen for VSD (0.172±0.011 among normal, 0.156±0.017 in mild POAG, and 0.142±0.018 in moderate-severe glaucoma; *P*=0.020 for normal vs mild; *P*=0.036 for mild vs moderate-severe) and VCI (2.55±0.19 among normal, 2.26±0.23 in mild POAG, and 1.97±0.28 in moderate-severe glaucoma; *P*=0.0024 for normal vs mild; *P*=0.0047 for mild vs moderate-severe), as shown in [Table 2](#t2-opth-12-2285){ref-type="table"}. Similarly, global RNFL thickness was reduced in mild (*P*=0.014) and moderate-severe POAG (*P*=0.0042) compared to normal, and lower in moderate-severe POAG than in mild (*P*=0.022).

Focal differences in perfusion parameters followed consistent patterns when analyzed by hemisphere and by quadrant. In the inferior hemisphere, VAD, VSD, and VCI were significantly lower in mild POAG than in normal subjects (Ps=0.0081, 0.0059, 0.00020, respectively), and lower in moderate-severe POAG than in mild POAG (Ps=0.021, 0.016, 0.042). In the superior hemisphere, however, while moderate-severe POAG patients demonstrated lower VAD, VSD, and VCI than in normal subjects (Ps=0.0076, 0.0076, 0.00020, respectively), no significant differences were detected between normal and mild POAG (except for VCI, *P*=0.00022) or between disease severities. Similarly, in the quadrant analysis, although VAD, VSD, and VCI were lower in all quadrants in moderate-severe POAG than in normal subjects (except VCI in the nasal quadrant, *P*=0.089), reductions in the same perfusion parameters in mild POAG compared to normal subjects were only evident in the superior (Ps=0.043, 0.018, 0.0046, respectively) and inferior (Ps=0.0024, 0.0011, 0.0019) quadrants. Focal reduction in perfusion parameters was not detected between mild and moderate-severe POAG in any quadrant (except VCI in the temporal quadrant, *P*=0.031). The same pattern of the inferior and superior quadrant showing significant focal reductions between normal and mild POAG (Ps=0.014, 0.0050, respectively) but not between mild and moderate-severe POAG was seen for RNFL thickness.

The strength of association of each perfusion parameter with functional (VF MD) and structural (RNFL thickness) measures was evaluated globally and focally. VAD, VSD, and VCI each demonstrated significant positive associations with VF MD globally (ßs=81.7, 167.4, 11.9; Ps=0.0007, 0.0013, \<0.0001, respectively), with pseudo *R*^2^ values, which can be interpreted as the amount of variation in VF MD that can be determined by the GEE model, ranging from 0.312 to 0.449 ([Table 3](#t3-opth-12-2285){ref-type="table"}). These associations remained significant between superior VF MD and corresponding VAD, VSD, and VCI (ßs=198.3, 419.4, 19.5; Ps=0.0003, 0.0004, \<0.0001, respectively), and between inferior VF MD and the same corresponding parameters (ßs=148.3, 347.9, 18.6; Ps=0.0005, 0.0005, \<0.0001). However, superior VF MD had qualitatively higher correlations with inferior VAD, VSD, and VCI (*R*^2^s=0.396, 0.390, 0.513, respectively) than inferior VF MD with corresponding perfusion parameters (*R*^2^s=0.208, 0.237, 0.378, respectively). [Table 4](#t4-opth-12-2285){ref-type="table"} shows that global VAD, VSD, and VCI were significantly associated with global RNFL thickness as well (ßs=242.1, 516.7, 32.5, respectively; all Ps\<0.0001), with pseudo *R*^2^ values ranging from 0.499 to 0.542. Associations between perfusion parameters and RNFL thickness in each quadrant were significant as well, with the excep tion of temporal VAD and VSD and corresponding RNFL thickness. The GEE models described in [Tables 3](#t3-opth-12-2285){ref-type="table"} and [4](#t4-opth-12-2285){ref-type="table"} controlled for inter-eye correlation.

[Table 5](#t5-opth-12-2285){ref-type="table"} demonstrates the diagnostic accuracy of each global perfusion parameter and RNFL thickness globally as measured by AUC, controlling for age and inter-eye correlation. Diagnostic accuracy was 0.868 for VAD (*P*\<0.0001), 0.855 for VSD (*P*\<0.0001), 0.868 for VCI (*P*\<0.0001), and 0.973 for RNFL thickness (*P*\<0.0001). There were no significant differences in diagnostic accuracy between any of the perfusion parameters and RNFL thickness (*P*=0.11 for VAD vs RNFL thickness; *P*=0.073 for VSD vs RNFL thickness; *P*=0.15 for VCI vs RNFL).

Discussion
==========

In this study of OCTA in POAG, we used a prototype OMAG software that allowed for precise segmentation and analysis of the RPCs. We observed a significant global reduction in each of these perfusion parameters in POAG patients compared to control subjects with "good" diagnostic ability[@b44-opth-12-2285] for each parameter in differentiating POAG from normal, comparable to RNFL thickness, as reported in previous studies.[@b29-opth-12-2285],[@b31-opth-12-2285],[@b38-opth-12-2285],[@b45-opth-12-2285]--[@b49-opth-12-2285]

All three global perfusion parameters, VAD, VSD, and VCI, in our study demonstrated significant stepwise differences between normal, mild POAG, and moderate-severe POAG. This stepwise difference was also evident for all three parameters for the inferior hemisphere, suggesting that the inferior region may have perfusion changes at an earlier stage of disease on average. In contrast, the superior hemisphere perfusion parameters mainly only had significant differences between normal and moderate-severe POAG. These data are consistent with the basic understanding that glaucomatous damage most often occurs first inferiorly, as has been demonstrated in structural OCT studies.[@b50-opth-12-2285]--[@b52-opth-12-2285]

In analyzing perfusion within particular quadrants, the inferior and superior quadrants were the best regions for distinguishing normal from mild disease for all perfusion parameters. In fact, this same result was also seen for quadrant RNFL thickness data. Interestingly, the quadrant data for both OCTA perfusion and OCT RNFL thickness were unable to detect differences between mild and moderate-severe disease. Though few studies have utilized orthogonal sector analysis, our findings corroborate those from previous studies that showed greater reductions in VAD and perfused capillary density in the inferior and superior quadrants.[@b38-opth-12-2285],[@b47-opth-12-2285],[@b49-opth-12-2285],[@b53-opth-12-2285] This supports the idea that early glaucomatous damage tends to be focal and most commonly in the inferior and superior locations, but later in disease, damage has a greater chance to become multifocal and thus a specific quadrant would be less likely to distinguish between the disease severities. There were significant differences for all four quadrants between normal and moderate-severe disease, suggesting that by the time there is more advanced disease, there is a more diffuse pattern of glaucomatous damage likely to affect all four quadrants. This trend was seen both for the three perfusion parameters, as well as for RNFL thickness, demonstrating that structural thickness and perfusion are affected similarly in glaucoma.

In terms of functional correlation, we found that VAD, VSD, and VCI were all associated with VF MD globally and for both hemispheres. Based on the GEE models, a global VF MD that is higher by approximately 0.8 dB is expected to occur with a VAD that is lower by 0.01. The correlation appeared qualitatively higher for the inferior perfusion parameters with superior VF MD than superior perfusion parameters with corresponding VF MD. This too may reflect the inferior nerve being more likely to have glaucomatous damage. While all were significant, the correlations of perfusion parameters with the structural measure of RNFL thickness globally were actually qualitatively higher than functional correlations. Although this observation has been made previously,[@b34-opth-12-2285],[@b48-opth-12-2285],[@b49-opth-12-2285],[@b54-opth-12-2285] others have found functional correlations to be stronger than structural ones,[@b29-opth-12-2285],[@b30-opth-12-2285],[@b32-opth-12-2285],[@b38-opth-12-2285],[@b45-opth-12-2285] and a longitudinal study of disease progression will be necessary to determine whether structural, functional, or vascular defects occur first. Nevertheless, given the limitations of OCT in diagnosing glaucoma in certain situations,[@b21-opth-12-2285],[@b55-opth-12-2285],[@b56-opth-12-2285] this suggests that OCTA has the potential to supplement OCT measures in diagnosis of glaucoma.

One of the key strengths of this study was the use of custom user-guided segmentation software, which allowed more precise analysis of the microcirculation at the RNFL. This is qualitatively evident in [Figure 2](#f2-opth-12-2285){ref-type="fig"}, which shows greater inferotemporal dropout in the custom segmented RNFL en face image on the right, while some of this contrast is lost in the automatically segmented image of the superficial retina on the left. Our study is one of few in the literature to implement this type of more manual segmentation, though other glaucoma studies have utilized the same prototype OMAG software with similar success,[@b35-opth-12-2285],[@b38-opth-12-2285] and Mammo et al used Amira software with speckle variance OCTA to correct automatically produced tracings.[@b36-opth-12-2285] The prototype OMAG software that we used also incorporated large vessel subtraction, another technique which allowed us to focus our analysis on the small-to-medium vessels. It is thought that large vessels change little with glaucoma progression, and in a recent 2-year prospective study, Holló demonstrated that while none of 44 glaucomatous eyes showed progression with peripapillary vessel density measurements, the removal of large retinal vessels in peripapillary capillary density measures resulted in the detection of progression in 17% of eyes.[@b57-opth-12-2285] We were able to target vessels even more selectively by using skeletonized vessel maps to reduce vessel width to one pixel, further emphasizing small capillary density in the VSD parameter. Using a similar method with AngioVue software, Geyman et al assessed whole-annulus perfused capillary density (AUC =0.907 for ability to distinguish mild POAG from control), a measure comparable to VSD, and found it to have somewhat higher diagnostic accuracy than the AngioAnalytics vessel density (AUC =0.851), comparable to VAD in this study, though the difference was not significant.[@b49-opth-12-2285] Although we did not find VSD (AUC =0.855) to be more diagnostically accurate than VAD (0.868), this could be because we used 6×6 mm^2^ scans, with possibly lower resolution (17 µm/pixel) than the 4.5×4.5 mm^2^ scans that the Geyman group used, potentially making it difficult to separate overlapping vessels. There is still no consensus as to the optimal image size for OCTA analysis, with peripapillary scan sizes as large as 6.72×6.72 mm^2^ having been used for glaucoma studies.[@b58-opth-12-2285] Future studies could compare scan sizes to determine the ideal balance between resolution and sufficient representation of damaged vascular regions.

Interestingly, while VCI demonstrated good diagnostic ability and significant associations with structural and functional measures, we observed that VCI decreased with glaucoma progression, contrary to our expectation that small vessel tortuosity, which VCI is designed to measure, may increase with disease severity. It is possible that VCI was simply detecting greater branching in healthy perfused vasculature, rather than tortuosity changes in diseased vessels; more study is needed to optimize our assessments of tortuous vessels.

This study was limited by a relatively small cohort, which prevented us from being able to further stratify POAG subjects into mild, moderate, and severe groups. In addition, although we found VAD, VSD, and VCI to be reliable correlates of existing functional and structural measures of glaucoma, the cross-sectional nature of this study precludes our ability to make any causal claims about the role of vascular dysfunction in the pathogenesis of POAG. The case--control design of this study also limits the generalizability of our findings to a true clinic population. In addition, multiple tests were performed in this study without multiple testing correction. While this may have led to some false positive results, it also reduces the risk of inflated false negative. Thus, results with borderline significance, such as the global and hemispheric differences in vessel parameters between disease severities and correlations with nasal RNFL thickness, should be interpreted with caution. The association of timolol treatment with moderate-severe glaucoma was significant and, because we still do not understand the effects of glaucoma treatment on peripapillary microcirculation, this cannot be ignored. The pre-OCTA literature suggests that while IOP decreases in glaucoma patients treated with topical timolol, OBF does not increase[@b59-opth-12-2285],[@b60-opth-12-2285] and often declines.[@b61-opth-12-2285],[@b62-opth-12-2285] Many studies confirm, however, that treatment with timolol in combination with dorzolamide[@b63-opth-12-2285],[@b64-opth-12-2285] or, as was more recently demonstrated, brimonidine[@b64-opth-12-2285] elevates OBF in addition to lowering IOP. In our study, in all cases but one, timolol treatment was provided in combination with dorzolamide and/or brimonidine, so we do not expect medication use to have caused reduced OBF. While age did not differ significantly between any of the groups in this study, prospective studies would benefit from age matching. Finally, while we did use the FastTrac algorithm to reduce motion artifact, trace amounts of artifact remained in some images.

Conclusion
==========

We demonstrated stepwise differences in global peripapillary perfusion parameters across POAG disease severities with good correlations to functional and structural disease measures. When looking at focal sectors, perfusion in the inferior hemisphere and inferior and superior quadrants were best at distinguishing normal from mild disease, but global parameters tended to be the better perfusion measure for distinguishing mild from moderate-severe POAG. Future studies should evaluate peripapillary perfusion longitudinally in glaucoma patients, study the effects of glaucoma treatments on perfusion measures, and should further explore which stages of disease severity demonstrate the greatest sequential changes in perfusion. This will move us toward a better understanding of the clinical utility of OCTA and its ability to supplement other clinical measures of disease.
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![En face images (6×6 mm^2^) of the radial peripapillary capillaries of the optic nerve head, acquired by automatic (left) and semi-automatic (right) segmentation.](opth-12-2285Fig1){#f1-opth-12-2285}

![Quadrants for focal analysis.\
**Abbreviations:** I, inferior quadrant; N, nasal quadrant; S, superior quadrant; T, temporal quadrant.](opth-12-2285Fig2){#f2-opth-12-2285}

![Moderate-severe glaucoma case (**A**) 6×6 mm^2^ en face image. (**B**) Skeletonized vessel image with large vessels removed. (**C**) Vessel density map with binary vessels, showing areas of higher vessel density in warmer colors. (**D**) Vessel complexity map with binary vessels, showing areas of greater vessel branching in warmer colors. (**E**) Cirrus OCT RNFL deviation map (top) and RNFL thickness by quadrant (bottom). (**F**) Probability total (left) and pattern (right) deviation maps.\
**Abbreviations:** I, inferior quadrant; N, nasal quadrant; OCT, optical coherence tomography; RNFL, retinal nerve fiber layer; S, superior quadrant; T, temporal quadrant.](opth-12-2285Fig3){#f3-opth-12-2285}

![Mild glaucoma case (**A**) 6×6 mm^2^ en face image. (**B**) Skeletonized vessel image with large vessels removed. (**C**) Vessel density map with binary vessels, showing areas of higher vessel density in warmer colors. (**D**) Vessel complexity map with binary vessels, showing areas of greater vessel branching in warmer colors. (**E**) Cirrus OCT RNFL deviation map (top) and RNFL thickness by quadrant (bottom). (**F**) Probability total (left) and pattern (right) deviation maps.\
**Abbreviations:** OCT, optical coherence tomography; RNFL, retinal nerve fiber layer.](opth-12-2285Fig4){#f4-opth-12-2285}

###### 

Demographic and clinical characteristics of normal and glaucomatous groups

  Variables                                      Normal eyes[a](#tfn1-opth-12-2285){ref-type="table-fn"}   Glaucomatous eyes[a](#tfn1-opth-12-2285){ref-type="table-fn"}   *P*-value[b](#tfn2-opth-12-2285){ref-type="table-fn"}   
  ---------------------------------------------- --------------------------------------------------------- --------------------------------------------------------------- ------------------------------------------------------- -------------
                                                                                                                                                                                                                                   
  Age (years)                                    55 (12)                                                   62 (12)                                                         64 (14)                                                 0.087
  Female sex                                     10 (59%)                                                  12 (63%)                                                        13 (68%)                                                0.604
  Hypertension                                   2 (12%)                                                   6 (32%)                                                         8 (42%)                                                 0.093
  Diabetes                                       1 (6%)                                                    4 (21%)                                                         4 (21%)                                                 0.495
  Number of glaucoma medications                 0                                                         1.63 (1.21)                                                     2.00 (1.63)                                             0.961
  Eyes on timolol                                0                                                         1 (5%)                                                          8 (42%)                                                 **0.029**
  Eyes on brimonidine                            0                                                         8 (42%)                                                         8 (42%)                                                 0.642
  Eyes on prostaglandin analogs                  0                                                         14 (74%)                                                        13 (68%)                                                0.544
  Eyes on carbonic anhydrase inhibitors          0                                                         7 (37%)                                                         6 (32%)                                                 0.203
  History of glaucoma surgery                    0                                                         3 (16%)                                                         6 (32%)                                                 0.646
  Central corneal thickness (µm)                 562 (38)                                                  550 (32)                                                        550 (46)                                                0.458
  Intraocular Pressure (mmHg)                    13.8 (3.8)                                                12.4 (3.6)                                                      14.0 (4.7)                                              0.700
  Visual field mean deviation (dB)               −1.04 (1.11)                                              −3.68 (1.93)                                                    −11.4 (5.42)                                            **0.011**
  Visual field pattern standard deviation (dB)   1.55 (0.35)                                               6.14 (2.39)                                                     9.03 (3.27)                                             **0.0031**
  Cup-disc ratio                                 0.42 (0.17)                                               0.74 (0.22)                                                     0.84 (0.14)                                             **0.00021**

**Notes:**

All data listed as mean (standard deviation) or frequency (percent).

*P*-values listed for normal vs glaucoma, except for treatment-related parameters, which are between disease severities. Person-specific continuous variables based on Wilcoxon rank sum test on normal and glaucoma eyes; eye-specific variables based on clustered Wilcoxon rank sum test, adjusting for inter-eye correlation. Fisher's exact test used for categorical variables, including glaucoma treatments between disease severities; unable to control for inter-eye correlation, so only one eye from patients contributing both eyes was taken into account. Significant *P*-value\<0.05 shown in bold.

###### 

Mean OCTA parameter and OCT RNFL thickness values for normal subjects, mild, and moderate-severe POAG patients

  Parameters                                                                  Normal          Mild POAG       Moderate-severe POAG   *P*-values[a](#tfn3-opth-12-2285){ref-type="table-fn"}                
  --------------------------------------------------------------------------- --------------- --------------- ---------------------- -------------------------------------------------------- ------------ --------------
                                                                                                                                                                                                           
  **Global data**                                                                                                                                                                                          
  Vessel area density (VAD)                                                   0.371 (0.024)   0.336 (0.036)   0.308 (0.037)          **0.010**                                                **0.035**    **0.00021**
  Vessel skeleton density (VSD)                                               0.172 (0.011)   0.156 (0.017)   0.142 (0.018)          **0.020**                                                **0.036**    **0.00032**
  Vessel complexity index (VCI)[b](#tfn4-opth-12-2285){ref-type="table-fn"}   2.55 (0.19)     2.26 (0.23)     1.97 (0.28)            **0.0024**                                               **0.0047**   **0.00018**
  RNFL thickness (µm)                                                         101.3 (15.1)    72.7 (9.3)      65.6 (6.9)             **0.014**                                                **0.022**    **0.0042**
                                                                                                                                                                                                           
  **Hemisphere data**                                                                                                                                                                                      
  VAD -- hemisphere data                                                                                                                                                                                   
   Inferior                                                                   0.439 (0.020)   0.406 (0.030)   0.366 (0.052)          **0.0081**                                               **0.021**    **0.00032**
   Superior                                                                   0.442 (0.019)   0.417 (0.042)   0.398 (0.044)          0.19                                                     0.053        **0.0076**
  VSD -- hemisphere data                                                                                                                                                                                   
   Inferior                                                                   0.207 (0.008)   0.192 (0.013)   0.171 (0.025)          **0.0059**                                               **0.016**    **0.00016**
   Superior                                                                   0.207 (0.008)   0.195 (0.018)   0.186 (0.022)          0.099                                                    0.10         **0.0076**
  VCI -- hemisphere data                                                                                                                                                                                   
   Inferior                                                                   3,860 (230)     3,271 (309)     2,852 (562)            **0.00020**                                              **0.042**    **0.000094**
   Superior                                                                   3,971 (216)     3,419 (434)     3,220 (452)            **0.00022**                                              0.12         **0.00020**
                                                                                                                                                                                                           
  **Quadrant data**                                                                                                                                                                                        
  VAD -- quadrant data                                                                                                                                                                                     
   T                                                                          0.439 (0.031)   0.424 (0.046)   0.390 (0.054)          0.76                                                     0.12         **0.016**
   S                                                                          0.440 (0.027)   0.406 (0.060)   0.396 (0.055)          **0.043**                                                0.18         **0.012**
   N                                                                          0.425 (0.041)   0.391 (0.068)   0.366 (0.061)          0.26                                                     0.060        **0.018**
   I                                                                          0.448 (0.026)   0.404 (0.030)   0.365 (0.063)          **0.0024**                                               0.067        **0.00063**
  VSD -- quadrant data                                                                                                                                                                                     
   T                                                                          0.207 (0.014)   0.200 (0.020)   0.184 (0.025)          0.68                                                     0.11         **0.019**
   S                                                                          0.207 (0.010)   0.190 (0.031)   0.183 (0.028)          **0.018**                                                0.19         **0.0053**
   N                                                                          0.196 (0.019)   0.183 (0.032)   0.170 (0.031)          0.41                                                     0.090        **0.036**
   I                                                                          0.212 (0.010)   0.191 (0.014)   0.170 (0.030)          **0.0011**                                               0.065        **0.00029**
  VCI -- quadrant data                                                                                                                                                                                     
   T                                                                          1,543 (167)     1,457 (166)     1,228 (223)            0.16                                                     **0.031**    **0.0005**
   S                                                                          1,481 (100)     1,312 (268)     1,232 (256)            **0.0046**                                               0.18         **0.0014**
   N                                                                          1,353 (203)     1,257 (291)     1,169 (273)            0.55                                                     0.16         0.089
   I                                                                          1,506 (95)      1,262 (221)     1,082 (241)            **0.0019**                                               0.063        **0.00011**
  RNFL thickness (µm) -- quadrant data                                                                                                                                                                     
   T                                                                          71.4 (10.3)     58.4 (15.3)     55.8 (10.5)            0.16                                                     0.68         **0.027**
   S                                                                          120.6 (22.2)    85.1 (19.7)     83.5 (18.5)            **0.014**                                                0.82         **0.0073**
   N                                                                          78.3 (10.6)     64.3 (10.0)     62.1 (8.6)             0.067                                                    0.33         **0.012**
   I                                                                          134.6 (23.3)    79.3 (15.8)     70.79 (21.0)           **0.0050**                                               0.15         **0.0034**

**Notes:**

*P*-values are based on clustered Wilcoxon rank sum test, controlling for inter-eye correlation, between: normal vs mild POAG; mild vs moderate-severe POAG; normal vs moderate-severe POAG.

Global VCI values divided by 10^9^. Significant *P*-value\<0.05 shown in bold.

**Abbreviations:** I, inferior quadrant; N, nasal quadrant; OCTA, optical coherence tomography angiography; POAG, primary open-angle glaucoma; RNFL, retinal nerve fiber layer; S, superior quadrant; T, temporal quadrant.

###### 

Linear regression[a](#tfn6-opth-12-2285){ref-type="table-fn"} of VF MD on OCTA parameters globally and by hemisphere in POAG

                   Mean (SD)      Corresponding vessel area density   Corresponding vessel skeleton density   Corresponding VCI                                                              
  ---------------- -------------- ----------------------------------- --------------------------------------- ------------------- ------- ------------ --------------- ------ -------------- ---------------
                                                                                                                                                                                             
  Global VF MD     −7.44 (5.63)   81.7                                **0.0007**                              0.770 (0.449)       167.4   **0.0013**   0.558 (0.312)   11.9   \<**0.0001**   0.632 (0.399)
  Superior VF MD   −8.31 (7.96)   198.3                               **0.0003**                              0.629 (0.396)       419.4   **0.0004**   0.624 (0.390)   19.5   \<**0.0001**   0.717 (0.513)
  Inferior VF MD   −6.83 (5.65)   148.3                               **0.0005**                              0.456 (0.208)       347.9   **0.0005**   0.486 (0.237)   18.6   \<**0.0001**   0.615 (0.378)

**Notes:**

Controlled for inter-eye correlation.

"Pseudo" *R*^2^ reported as the coefficient of determination resulting from linear regression by the generalized estimating equation technique, to be interpreted as the amount of VF MD that can be explained by the model.

Beta values for VCI scaled per 10^9^ change in VCI; focal beta values for VCI scaled per 10^3^ change in VCI. Significant *P*-value\<0.05 shown in bold.

**Abbreviations:** OCTA, optical coherence tomography angiography; POAG, primary open-angle glaucoma; VCI, vessel complexity index; VF MD, visual field mean deviation.

###### 

Linear regression[a](#tfn10-opth-12-2285){ref-type="table-fn"} of RNFL thickness on OCTA parameters globally and by quadrant in glaucoma

                   Mean (SD)     Corresponding vessel area density   Corresponding vessel skeleton density   Corresponding VCI                                                                
  ---------------- ------------- ----------------------------------- --------------------------------------- ------------------- ------- -------------- --------------- ------ -------------- ---------------
                                                                                                                                                                                              
  Global RNFLt     69.2 (8.8)    242.1                               \<**0.0001**                            0.706 (0.499)       516.7   \<**0.0001**   0.724 (0.524)   32.5   \<**0.0001**   0.736 (0.542)
                                                                                                                                                                                              
  **Quadrants**                                                                                                                                                                               
  Temporal RNFLt   57.1 (13.0)   50.0                                0.091                                   0.462 (0.213)       142.1   **0.0238**     0.482 (0.232)   11.4   0.13           0.465 (0.216)
  Superior RNFLt   84.3 (18.9)   206.1                               \<**0.0001**                            0.541 (0.292)       425.9   \<**0.0001**   0.563 (0.317)   53.5   \<**0.0001**   0.628 (0.394)
  Nasal RNFLt      63.2 (9.3)    68.3                                **0.037**                               0.510 (0.260)       138.2   **0.0497**     0.501 (0.251)   15.8   **0.034**      0.507 (0.257)
  Inferior RNFLt   75.1 (18.8)   216.6                               **0.014**                               0.523 (0.274)       463.0   **0.033**      0.533 (0.285)   58.8   **0.0006**     0.614 (0.377)

**Notes:**

Controlled for inter-eye correlation.

"Pseudo" *R*^2^ reported as the coefficient of determination resulting from linear regression by the generalized estimating equation technique, to be interpreted as the amount of RNFLt that can be explained by the model.

Global beta values for VCI scaled per 10^9^ change in VCI; focal beta values for VCI scaled per 10^3^ change in VCI. Significant *P*-value\<0.05 shown in bold.

**Abbreviations:** OCTA, optical coherence tomography angiography; POAG, primary open-angle glaucoma; RNFL, retinal nerve fiber layer; RNFLt, retinal nerve fiber layer thickness; VCI, vessel complexity index.

###### 

Diagnostic accuracy of OCTA parameters

                   Area under curve statistic[a](#tfn14-opth-12-2285){ref-type="table-fn"}   *P*-value
  ---------------- ------------------------------------------------------------------------- -----------
                                                                                             
  VAD              0.868                                                                     \<0.0001
  VSD              0.855                                                                     \<0.0001
  VCI              0.868                                                                     \<0.0001
  RNFL thickness   0.973                                                                     \<0.0001

**Notes:**

Controlled for age and inter-eye correlation. *P*-values for area under curve contrasts between VAD-VSD, VAD-VCI, VSD-VCI, VAD-RNFL, VSD-RNFL, and VCI-RNFL were all \>0.05.

**Abbreviations:** OCTA, optical coherence tomography angiography; RNFL, retinal nerve fiber layer; VAD, vessel area density; VSD, vessel skeleton density; VCI, vessel complexity index.
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